Efficacy and Safety of Adjunctive Everolimus for Treatment-Refractory Seizures Associated With Tuberous Sclerosis Complex (TSC) in Children Under 6 Years of Age: Results From the Phase 3 EXIST-3 Extension Phase

被引：0
|
作者：
Franz, D.
Lawson, J.
Yapici, Z.
Ikeda, H.
Polster, T.
Nabbout, R.
Curatolo, P.
de Vries, P.
Dlugos, D.
Fan, J.
Louveau, A.
Pelov, D.
Voi, M.
French, J.
机构：
来源：
ANNALS OF NEUROLOGY | 2017年 / 82卷
关键词：
Epilepsy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
26
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 17 条
  • [1] Sustained Seizure Reduction With Adjunctive Everolimus for Treatment-Refractory Seizures Associated With Tuberous Sclerosis Complex (TSC): Long-Term Results From the Phase 3 EXIST-3 Study
    Franz, D.
    Lawson, J.
    Yapici, Z.
    Ikeda, H.
    Polster, T.
    Nabbout, R.
    Curatolo, P.
    de, Vries P.
    Dlugos, D.
    Voi, M.
    Fan, J.
    Louveau, A.
    Pelov, P.
    French, J.
    ANNALS OF NEUROLOGY, 2017, 82 : S281 - S282
  • [2] Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3
    Franz, David N.
    Lawson, John A.
    Yapici, Zuhal
    Ikeda, Hiroko
    Polster, Tilman
    Nabbout, Rima
    Curatolo, Paolo
    Vries, Petrus J.
    Dlugos, Dennis J.
    Herbst, Fabian
    Peyrard, Severine
    Pelov, Diana
    French, Jacqueline A.
    EPILEPSIA, 2021, 62 (12) : 3029 - 3041
  • [3] Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial
    Curatolo, Paolo
    Franz, David N.
    Lawson, John A.
    Yapici, Zuhal
    Ikeda, Hiroko
    Polster, Tilman
    Nabbout, Rima
    de Vries, Petrus J.
    Dlugos, Dennis J.
    Fan, Jenna
    Ridolfi, Antonia
    Pelov, Diana
    Voi, Maurizio
    French, Jacqueline A.
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (07) : 495 - 504
  • [4] Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-refractory Seizures: Subanalysis of the Phase 3 EXIST-3 Study
    Franz, D.
    Lawson, J.
    Yapici, Z.
    Ikeda, H.
    Polster, T.
    Nabbout, R.
    de Vries, P.
    Dlugos, D.
    Mookerjee, B.
    Fan, J.
    Lixian, J.
    Ridolfi, A.
    Herbst, F.
    French, J.
    ANNALS OF NEUROLOGY, 2018, 84 : S337 - S337
  • [5] Long-term Efficacy and Safety of Everolimus Among Pediatric Patients with Tuberous Sclerosis Complex (TSC) and Treatment-refractory Seizures: Final Analysis of the EXIST-3 Study
    Hertzberg, C.
    Belousova, E.
    Fan, P.
    De Waele, L.
    Bjoernvold, M.
    Nabbout, R.
    de Vries, P.
    Fan, J.
    Jin, L.
    Herbst, F.
    Ridolfi, A.
    Franz, D.
    ANNALS OF NEUROLOGY, 2018, 84 : S345 - S345
  • [6] Efficacy and Safety of Adjunctive Everolimus for Treatment-Resistant Focal-Onset Seizures in Tuberous Sclerosis According to Age: Insights From EXIST-3
    Roberts, C.
    Kuperman, R.
    Koenig, M.
    Wilfong, A.
    Wu, J.
    Kohrman, M.
    Curatolo, P.
    Nabbout, R.
    Fan, J.
    Herbst, F.
    Ridolfi, A.
    Franz, D.
    ANNALS OF NEUROLOGY, 2017, 82 : S295 - S295
  • [7] Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated With Tuberous Sclerosis Complex: Results From a Randomized, Placebo-Controlled, Phase 3 Trial
    Franz, D.
    Lawson, J.
    Nabbout, R.
    Curatolo, P.
    de Vries, P.
    Berkowitz, N.
    Voi, M.
    Peyrard, S.
    Vaury, A.
    French, J.
    Yapici, Z.
    ANNALS OF NEUROLOGY, 2016, 80 : S316 - S316
  • [8] Psychometric Evaluation of Quality of Life in a Three-Arm, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-Onset Seizures (EXIST-3)
    Franz, D.
    de Vries, P.
    Curatolo, P.
    Nabbout, R.
    Fan, J.
    Neary, M.
    Herbst, F.
    Sully, K.
    Brohan, E.
    Lawson, J.
    ANNALS OF NEUROLOGY, 2017, 82 : S282 - S282
  • [9] Efficacy and Safety of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC) in Pediatric Patients Enrolled in a Phase 3 Trial With an Open-Label Extension (OLE)
    Thiele, E.
    Lawson, J.
    Kotulska, K.
    Sahebkar, F.
    Greco, T.
    Saurer, T.
    ANNALS OF NEUROLOGY, 2023, 94 : S57 - S57
  • [10] Efficacy and Safety of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC) in Pediatric Patients Enrolled in a Phase 3 Trial With an Open-Label Extension (OLE)
    Thiele, E.
    Lawson, J.
    Kotulska, K.
    Sahebkar, F.
    Greco, T.
    Saurer, T.
    ANNALS OF NEUROLOGY, 2023, 94 : S55 - S55
12